TRIB
Price:
$1.69
Market Cap:
$19.22M
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identify...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1992-10-21
Stock Exchange
NASDAQ
Ticker
TRIB
According to Trinity Biotech plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.63. This represents a change of -35.18% compared to the average of -0.97 of the last 4 quarters.
The mean historical PE Ratio of Trinity Biotech plc over the last ten years is 6.54. The current -0.63 PE Ratio has changed -1063.19% with respect to the historical average. Over the past ten years (40 quarters), TRIB's PE Ratio was at its highest in in the September 2019 quarter at 252.91. The PE Ratio was at its lowest in in the September 2016 quarter at -145.73.
Average
6.54
Median
-0.75
Minimum
-13.24
Maximum
34.16
Discovering the peaks and valleys of Trinity Biotech plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 149.16%
Maximum Annual PE Ratio = 34.16
Minimum Annual Increase = -820.14%
Minimum Annual PE Ratio = -13.24
Year | PE Ratio | Change |
---|---|---|
2023 | -0.69 | -15.87% |
2022 | -0.81 | -102.38% |
2021 | 34.16 | -357.93% |
2020 | -13.24 | 149.16% |
2019 | -5.32 | -126.54% |
2018 | 20.03 | -820.14% |
2017 | -2.78 | 76.11% |
2016 | -1.58 | -112.64% |
2015 | 12.50 | -46.00% |
2014 | 23.14 | -56.62% |
The current PE Ratio of Trinity Biotech plc (TRIB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.89
5-year avg
2.82
10-year avg
6.54
Trinity Biotech plc’s PE Ratio is greater than Star Equity Holdings, Inc. (-1.74), greater than Standard BioTools Inc. (-6.26), less than Genetron Holdings Limited (-0.63), greater than Biodesix, Inc. (-4.64), less than ENDRA Life Sciences Inc. (-0.29), greater than Sera Prognostics, Inc. (-8.30), greater than Olink Holding AB (publ) (-96.25), less than FONAR Corporation (6.08), greater than Neuronetics, Inc. (-1.01), greater than Exagen Inc. (-2.59), less than Sotera Health Company (111.47), greater than Aclaris Therapeutics, Inc. (-2.64), greater than Castle Biosciences, Inc. (-300.10), greater than Prenetics Global Limited (-1.03), greater than MDxHealth SA (-1.36), less than Inotiv, Inc. (-0.46),
Company | PE Ratio | Market cap |
---|---|---|
-1.74 | $11.60M | |
-6.26 | $779.42M | |
-0.63 | $127.29M | |
-4.64 | $201.80M | |
-0.29 | $4.66M | |
-8.30 | $257.59M | |
-96.25 | $3.24B | |
6.08 | $92.08M | |
-1.01 | $33.04M | |
-2.59 | $42.94M | |
111.47 | $4.47B | |
-2.64 | $154.82M | |
-300.10 | $933.07M | |
-1.03 | $53.27M | |
-1.36 | $100.97M | |
-0.46 | $45.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trinity Biotech plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Trinity Biotech plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Trinity Biotech plc's PE Ratio?
How is the PE Ratio calculated for Trinity Biotech plc (TRIB)?
What is the highest PE Ratio for Trinity Biotech plc (TRIB)?
What is the 3-year average PE Ratio for Trinity Biotech plc (TRIB)?
What is the 5-year average PE Ratio for Trinity Biotech plc (TRIB)?
How does the current PE Ratio for Trinity Biotech plc (TRIB) compare to its historical average?